Konstantinos Stergiou

Mr. Konstantinos Stergiou

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Vasilis Spyridon TseriotisVasilis Spyridon Tseriotis
Vasilis Spyridon Tseriotis
DADimitrios Ampazis
Dimitrios Ampazis
Sofia KarachrysafiSofia Karachrysafi
Sofia Karachrysafi
Theodora PapamitsouTheodora Papamitsou
Theodora Papamitsou
GPGeorgios Petrakis
Georgios Petrakis
MAMarianthi Arnaoutoglou
Marianthi Arnaoutoglou
Cancer, a leading global cause of death responsible for nearly 10 million deaths annually, demands innovative therapeutic strategies. Intrinsic cytotoxicity and biocompatibility of zinc oxide nanoparticles (ZnO-NPs) have rendered them promising nanoplatforms in oncology. We herein systematically review their applications for targeted cancer chemotherapy, with a focus on physicochemical properties, drug delivery mechanisms, and interactions with the tumor microenvironment (TME). We searched PubMed, SCOPUS, and Web of Science from inception through December 2024 for peer-reviewed preclinical studies on cancer models. Results were qualitatively synthesized. Quality was assessed with the SYRCLE risk of bias tool. Among 20 eligible studies, ZnO-NPs were frequently functionalized with ligands to enhance tumor targeting and minimize systemic toxicity. Chemotherapeutic agents (doxorubicin, 5-fluorouracil, docetaxel, cisplatin, gemcitabine, and tirapazamine) were loaded into ZnO-based carriers, with improved anticancer efficacy compared to free drug formulations, particularly in multidrug-resistant cell lines and in vivo murine xenografts. The mildly acidic TME was exploited for pH-responsive drug release, premature leakage reduction, and improvement of intratumoral accumulation. Enhanced therapeutic outcomes were attributed to reactive oxygen species generation, zinc ion-mediated cytotoxicity, mitochondrial dysfunction, and efflux pump inhibition. Deep tumor penetration, apoptosis induction, and tumor growth suppression were also reported, with minimal toxicity to healthy tissues. ZnO-NPs might constitute a versatile and promising strategy for targeted cancer chemotherapy, offering synergistic anticancer effects and improved safety profiles. Future studies emphasizing long-term toxicity, immune responses, and scalable production could lead to clinical translation of ZnO-based nanomedicine in oncology.

30 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
GKGeorgios Kiosis
Georgios Kiosis
DIDespoina Ioannou
Despoina Ioannou
KSKanellos Skourtsidis
Kanellos Skourtsidis
VFVasileios Fouskas
Vasileios Fouskas
KSKonstantinos Stergiou
Konstantinos Stergiou
MKMaria Kourti
Maria Kourti
Background/Objectives: Sarcopenia, defined as the progressive loss of muscle mass and function, is increasingly recognized in pediatric cancer patients as a significant clinical and prognostic factor. Sarcopenia in children arises from malignancy-related inflammation, malnutrition, and treatment toxicity, negatively affecting treatment response, recovery, and quality of life. Methods: We searched MEDLINE and Scopus for English-written articles published over the last five years using synonyms for the terms “sarcopenia” and “pediatric cancer”. Screening and data extraction were performed in a duplicate-blinded method. We qualitatively synthesized eligible articles. Results: Recent studies identify pre-treatment sarcopenia as a marker of poor prognosis, especially in hepatoblastoma and neuroblastoma. Total psoas muscle area (tax) and skeletal muscle index (SMI) are emerging diagnostic tools, though standardized methods remain lacking. Sarcopenia’s etiology is multifactorial, involving impaired mitochondrial metabolism, chemotherapy-induced appetite loss, and systemic inflammation. Sarcopenic obesity is common, particularly among leukemia survivors, often masked by normal BMI. Survivors also face reduced bone density, impaired immunity, and persistent muscle loss, linked to prior therapies such as radiotherapy and hematopoietic stem cell transplantation. Increase in muscle mass post-treatment correlates with better survival outcomes. Conclusions: Early detection of sarcopenia can support timely interventions such as nutritional support and physical activity. Yet, significant diagnostic heterogeneity across existing studies hampers definitive conclusions regarding its true prevalence and the optimal assessment method. Standardized diagnostic criteria are urgently needed to enable more reliable prevalence estimates and evidence-based clinical strategies.

19 January 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
KSKonstantinos Stergiou
Konstantinos Stergiou
KSKanellos Skourtsidis
Kanellos Skourtsidis
GKGeorgios Kiosis
Georgios Kiosis
DIDespoina Ioannou
Despoina Ioannou
Vasilis Spyridon TseriotisVasilis Spyridon Tseriotis
Vasilis Spyridon Tseriotis
MKMaria Kourti
Maria Kourti
Candidozyma auris (previously named Candida auris) has been recognized as a significant public health threat due to its extensive transmission in hospital settings, high mortality rates, and multidrug resistance. Evidence regarding optimal antifungal treatment in children remains limited. The present systematic review aims to synthesize available evidence on pediatric C. auris infections, focusing on antifungal treatment, resistance profiles, and clinical outcomes. A systematic search was conducted across PubMed, Scopus, and Web of Science, identifying case reports and case series of pediatric patients with confirmed C. auris infection. Data were extracted on demographics, comorbidities, infection site, antifungal therapy, and outcomes. Risk of bias was assessed using JBI Critical Appraisal checklists. Fourteen studies comprising 62 patients were included, with most cases being bloodstream infections. C. auris showed widespread fluconazole resistance and variable susceptibility to amphotericin B. Echinocandins were the most commonly used agents, generally associated with survival. Overall mortality was 35%, similar to that reported for adults. Combination therapy showed numerically higher survival, although given the small sample size and heterogeneity of treatment regimens, no comparative inferences can be made. Pediatric C. auris infections mirror adult patterns of antifungal resistance and mortality. Echinocandins remain first line therapy; however, the emergence of echinocandin resistance underscores the urgent need for antifungal stewardship, standardized pediatric guidelines, and novel antifungal development.

Verified
Journal Article
Open access
PDF file
GKGeorgios Kiosis
Georgios Kiosis
KSKanellos Skourtsidis
Kanellos Skourtsidis
DIDespoina Ioannou
Despoina Ioannou
Vasilis Spyridon TseriotisVasilis Spyridon Tseriotis
Vasilis Spyridon Tseriotis
KSKonstantinos Stergiou
Konstantinos Stergiou
Sofia KarachrysafiSofia Karachrysafi
Sofia Karachrysafi
(Background) Retinoblastoma is the most common intraocular malignancy in childhood, primarily caused by mutations in the RB1 gene. However, increasing evidence highlights the significant role of epigenetic mechanisms, particularly DNA methylation and histone acetylation, in tumor initiation and progression. This review aims to summarize and critically assess recent findings on how DNA methylation and histone acetylation contribute to the pathogenesis of retinoblastoma, and to explore their potential role as diagnostic biomarkers and therapeutic targets. (Methods) We searched the databases PubMed, Scopus, and ScienceDirect following PRISMA guidelines. Eligible studies were English-language, open-access articles published within the last ten years, including cohort studies, research articles, and case reports. After rigorous screening, 18 studies were included in the final analysis. (Results) Aberrant DNA methylation was found to inactivate tumor suppressor genes (RB1, RASSF1A, p16INK4A, MGMT) and promote oncogenesis through hypermethylation of regulatory elements. Similarly, histone acetylation’s dysregulation contributed to chromatin remodeling and overexpression of oncogenic factors such as SYK, GALNT8, and lincRNA-ROR. Elevated histone deacetylase (HDAC) activity was also linked to tumor cell proliferation, metastasis, and treatment resistance. Epigenetic inhibitors targeting these pathways demonstrated promising therapeutic potential. (Conclusions) DNA methylation and histone acetylation play a crucial role in the epigenetic regulation of genes implicated in retinoblastoma. Their dysregulation promotes tumorigenesis, and targeting these mechanisms represents a promising avenue for novel diagnostic and therapeutic strategies in pediatric oncology.

1 April 2026 in Life
Verified
Journal Article
Open access
PDF file
KSKanellos Skourtsidis
Kanellos Skourtsidis
DIDespoina Ioannou
Despoina Ioannou
GKGeorgios Kiosis
Georgios Kiosis
KSKonstantinos Stergiou
Konstantinos Stergiou
NGNefeli Maria Georgaki
Nefeli Maria Georgaki
Sofia KarachrysafiSofia Karachrysafi
Sofia Karachrysafi
Introduction: Chronic Kidney Disease (CKD) is a leading public health problem worldwide, with limited therapeutic options to halt its progression. Recent evidence implicates non-coding RNAs (ncRNAs), specifically long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), as critical regulators in renal pathophysiology and the transition from Acute Kidney Injury (AKI) to CKD. This review aims to synthesize recent findings regarding the role of ncRNAs in CKD pathogenesis, emphasizing their potential as diagnostic biomarkers and therapeutic targets. Methods: A systematic search was conducted in the PubMed/MEDLINE and Scopus databases for original research articles published over the last five years. Studies were selected based on specific eligibility criteria focusing on the correlation of ncRNAs with the development, diagnosis, and therapy of CKD. A total of 14 studies were included in the final review. Results: This review identified a dual landscape of ncRNAs function. Several lncRNAs, including H19, MALAT1, NEAT1_2, and LINC00963, were found to act as pathogenic drivers, promoting inflammation, apoptosis, and fibrosis through pathways such as TGF-β/Smad and NF-κB. Specifically, MALAT1 and NEAT1_2 are pivotal in driving the AKI-to-CKD transition. Conversely, specific miRNAs, such as miR-204, miR-26a, miR-451, miR-101, and miR-486-5p, exhibited protective effects by attenuating oxidative stress, preserving endothelial function, and inhibiting epithelial–mesenchymal transition (EMT). Dysregulation of these molecules was also observed in systemic conditions affecting the kidney, such as congestive heart failure and β-thalassemia. Conclusions: ncRNAs are central players in the molecular mechanisms underlying renal injury and maladaptive repair. The identified lncRNAs and miRNAs offer promising avenues for non-invasive diagnosis and the development of novel targeted therapies to prevent fibrosis and slow the progression of CKD.

Verified
Conference Paper
Open access
PDF file
KSKanellos Skourtsidis
Kanellos Skourtsidis
GKGeorgios Kiosis
Georgios Kiosis
DIDespoina Ioannou
Despoina Ioannou
NGNefeli Maria Georgaki
Nefeli Maria Georgaki
KSKonstantinos Stergiou
Konstantinos Stergiou
SKSofia Karachrysafi
Sofia Karachrysafi
Peripheral Artery Disease (PAD) is increasingly recognized as a complex environmental pathology driven by “contaminant metals,” rather than solely lifestyle factors. This scoping review (2016–2025) analyses the correlation between anthropogenic soil/water-derived Cadmium (Cd) and Lead (Pb) and progressive vascular hardening. The analysis confirms a robust, non-linear dose–response relationship. Chronic Cd exposure functions as a potent independent toxicant (Risk Ratio = 2.58 at 1 µg/L), significantly lowering Ankle–Brachial Index scores by inducing oxidative stress, inhibiting nitric oxide bioavailability, and displacing calcium in endothelial walls. Synergistically, Pb exposure, even at levels <5 µg/dL, compounds toxicity, amplifying arterial stiffness and hypertension. Consequently, “Heavy Metal Hardening” constitutes a critical link between water quality management and public health. Current regulatory thresholds appear insufficient to prevent chronic vascular remodeling, mandating urgent remediation of metal-laden aquifers and agricultural soils to mitigate this silent cardiovascular epidemic.